Swaminathan Arun has filed 4 insider transactions across 1 company since November 2024.
Most recent transaction: a grant/award of 293983 shares of Coya Therapeutics, Inc. ($COYA) on January 22, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Coya Therapeutics, Inc. | $COYA | Swaminathan Arun | Chief Executive Officer | A | Stock Option (right to buy) | 293983 | $0.00 | 293,983.0000 | 20,924,456 | 9999.99% | 1.41% |
| Jan. 9, 2025 | Coya Therapeutics, Inc. | $COYA | Swaminathan Arun | Chief Executive Officer | A | Stock Option (right to buy) | 240964 | $0.00 | 240,964.0000 | 0 | 9999.99% | 0.00% |
| Nov. 13, 2024 | Coya Therapeutics, Inc. | $COYA | Swaminathan Arun | Chief Executive Officer | P | Common Stock, par value $0.0001 per share | 5000 | $7.36 | 10,000.0000 | 0 | 100.00% | 0.00% |
| Nov. 11, 2024 | Coya Therapeutics, Inc. | $COYA | Swaminathan Arun | Chief Executive Officer | P | Common Stock, par value $0.0001 per share | 5000 | $7.34 | 5,000.0000 | 0 | 9999.99% | 0.00% |